Fasting Versus Nonfasting Triglycerides: Implications for Laboratory Measurements (Perspectives) Fasting Versus Nonfasting Triglycerides: Implications for Laboratory Measurements (Perspectives)

Fasting Versus Nonfasting Triglycerides: Implications for Laboratory Measurements (Perspectives‪)‬

Clinical Chemistry 2008, Jan, 54, 1

    • 2,99 €
    • 2,99 €

Beschreibung des Verlags

Recent publications in the Journal of the American Medical Association (1, 2) report the superiority of the measurement of nonfasting over conventional fasting triglycerides in predicting risk for cardiovascular events, observations consistent with previous studies (3, 4). For decades the usual practice has been to measure triglycerides in blood samples obtained after patients have fasted 8-12 h, a procedure consistent with population studies that specified fasting blood collections to decrease variability and achieve consistency of metabolic state in patients at the time of sample collection (5). Triglyceride values fluctuate widely over time, with a CV of biological variability averaging about 23% and ranging up to 40%, and this variability can confound estimation of the associated cardiovascular disease (CVD) risk (6). Fasting blood collection is thought to decrease this variability (7), a theory supported by the observed correlation between fasting and nonfasting values (8). Nevertheless, because postprandial nonfasting values are more representative of the usual metabolic state, the observed improved prediction of the associated CVD risk is not unexpected. A change in practice to nonfasting collections, however, might affect other applications of the triglyceride determination or other measurements made on the specimens. Triglycerides are measured in clinical practice not only to assess CVD risk, but also to detect the extreme increases that can contribute to pancreatitis. For this purpose the question of fasting vs nonfasting is largely irrelevant; in fact such high levels could be detected by visual observation of the extent of turbidity and/or a floating fat layer associated with the larger triglyceriderich lipoprotein (TRL) particles. Triglyceride-associated turbidity, likely increased in nonfasting specimens, can interfere with other laboratory determinations, necessitating thorough studies with various instrument/reagent systems.

GENRE
Wissenschaft und Natur
ERSCHIENEN
2008
1. Januar
SPRACHE
EN
Englisch
UMFANG
8
Seiten
VERLAG
American Association for Clinical Chemistry, Inc.
GRÖSSE
66,4
 kB

Mehr ähnliche Bücher

Fasting Versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?(Perspectives) Fasting Versus Nonfasting Triglycerides and the Prediction of Cardiovascular Risk: Do We Need to Revisit the Oral Triglyceride Tolerance Test?(Perspectives)
2008
Apolipoprotein C-III Bound to Apolipoprotein B-Containing Lipoproteins in Obese Girls (Technical Briefs) Apolipoprotein C-III Bound to Apolipoprotein B-Containing Lipoproteins in Obese Girls (Technical Briefs)
2003
Citation Classics in Lipid Measurement and Applications (Aacc 50th Anniversary Retrospective) Citation Classics in Lipid Measurement and Applications (Aacc 50th Anniversary Retrospective)
1998
High-Density Lipoproteins High-Density Lipoproteins
2011
Lipoproteins as Carriers of Pharmacological Agents Lipoproteins as Carriers of Pharmacological Agents
2017
Regulation Of Serum Lipids By Physical Exercise Regulation Of Serum Lipids By Physical Exercise
2018

Mehr Bücher von Clinical Chemistry

Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs) Highly Sensitive Immunoprecipitation Method for Extracting and Concentrating Low-Abundance Proteins from Human Serum (Technical Briefs)
2005
Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report) Longitudinal Concentrations of Vitamin [B.Sub.12] and Vitamin [B.Sub.12]-Binding Proteins During Uncomplicated Pregnancy (General Clinical Chemistry) (Clinical Report)
2002
Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs) Multicenter Characterization and Validation of the Intron-8 Poly(T) Tract (IVS8-T) Status in 25 Coriell Cell Repository Cystic Fibrosis Reference Cell Lines for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Gene Mutation Assays (Technical Briefs)
2004
Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report) Immunoassay Standardization: Is It Possible, Who Is Responsible, Who Is Capable?(Opinion) (Clinical Report)
2001
A Conversation with Elizabeth Blackburn (Interview) A Conversation with Elizabeth Blackburn (Interview)
2009
The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective) The Evolution of Immunoassay As Seen Through the Journal Clinical Chemistry (Aacc 50th Years Anniversary Retrospective)
1998